200 related articles for article (PubMed ID: 17911142)
1. Schedules for hepatitis B vaccination of risk groups: balancing immunogenicity and compliance.
Van Herck K; Leuridan E; Van Damme P
Sex Transm Infect; 2007 Oct; 83(6):426-32. PubMed ID: 17911142
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Accelerated and Standard Hepatitis B Vaccination Schedules in High-Risk Healthy Adults: A Meta-Analysis of Randomized Controlled Trials.
Jin H; Tan Z; Zhang X; Wang B; Zhao Y; Liu P
PLoS One; 2015; 10(7):e0133464. PubMed ID: 26196903
[TBL] [Abstract][Full Text] [Related]
3. Short-term immunogenicity of standard and accelerated hepatitis B virus vaccination schedules in healthy adults: a comparative field study in China.
Zhang X; Wang J; Chen X; Yu M; Yu S; Sun Y; Duan J; Sun H; Yuan P
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30201691
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B vaccination schedules in genitourinary medicine clinics.
Asboe D; Rice P; de Ruiter A; Bingham JS
Genitourin Med; 1996 Jun; 72(3):210-2. PubMed ID: 8707326
[TBL] [Abstract][Full Text] [Related]
5. Compliance and immunogenicity of two hepatitis B vaccination schedules in sex workers in Belgium.
Wouters K; Leuridan E; Van Herck K; Van Ardenne N; Roelofs I; Mak R; Prévost C; Guérin P; Denis B; Van Damme P
Vaccine; 2007 Feb; 25(10):1893-900. PubMed ID: 17239492
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
7. Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.
Young MD; Gooch WM; Zuckerman AJ; Du W; Dickson B; Maddrey WC
J Med Virol; 2001 Jul; 64(3):290-8. PubMed ID: 11424117
[TBL] [Abstract][Full Text] [Related]
8. Comparison of accelerated and rapid schedules for monovalent hepatitis B and combined hepatitis A/B vaccines in children with cancer.
Köksal Y; Varan A; Aydin GB; Sari N; Yazici N; Yalcin B; Kutluk T; Akyuz C; Büyükpamukçu M
Pediatr Hematol Oncol; 2007 Dec; 24(8):587-94. PubMed ID: 18092249
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients.
el-Reshaid K; al-Mufti S; Johny KV; Sugathan TN
Vaccine; 1994; 12(3):223-34. PubMed ID: 8165854
[TBL] [Abstract][Full Text] [Related]
10. Early anti-HBs antibody response to accelerated and to conventional hepatitis B vaccination regimens in healthy persons.
Harries AD; Clark M; Beeching NJ; Lavelle J; Mutton KJ
J Infect; 1991 Nov; 23(3):251-4. PubMed ID: 1836486
[TBL] [Abstract][Full Text] [Related]
11. The place of accelerated schedules for hepatitis A and B vaccinations.
Zuckerman J
Drugs; 2003; 63(17):1779-84. PubMed ID: 12921484
[TBL] [Abstract][Full Text] [Related]
12. Long-term effectiveness of accelerated hepatitis B vaccination schedule in drug users.
Shah DP; Grimes CZ; Nguyen AT; Lai D; Hwang LY
Am J Public Health; 2015 Jun; 105(6):e36-43. PubMed ID: 25880946
[TBL] [Abstract][Full Text] [Related]
13. Comparison of immunogenicity between hepatitis B vaccines with different dosages and schedules among healthy young adults in China: A 2-year follow-up study.
Wang ZZ; Gao YH; Wang P; Wei L; Xie CP; Yang ZX; Lan J; Fang ZL; Zeng Y; Yan L; Liu XE; Zhuang H
Hum Vaccin Immunother; 2018 Jun; 14(6):1475-1482. PubMed ID: 29420134
[TBL] [Abstract][Full Text] [Related]
14. Higher rate of long-term serologic response of four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: 4-year follow-up of a randomised controlled trial.
Chaiwarith R; Praparattanapan J; Kotarathititum W; Wipasa J; Chaiklang K; Supparatpinyo K
AIDS Res Ther; 2019 Nov; 16(1):33. PubMed ID: 31711528
[TBL] [Abstract][Full Text] [Related]
15. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
[TBL] [Abstract][Full Text] [Related]
16. Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.
Keating GM; Noble S
Drugs; 2003; 63(10):1021-51. PubMed ID: 12699402
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of the immunogenicity and safety of two dosing schedules of Engerix-B hepatitis B vaccine in neonates.
Goldfarb J; Baley J; Medendorp SV; Seto D; Garcia H; Toy P; Watson B; Gooch MW; Krause D
Pediatr Infect Dis J; 1994 Jan; 13(1):18-22. PubMed ID: 8170727
[TBL] [Abstract][Full Text] [Related]
18. Optimal vaccination program for healthy adults in China.
Yao J; Qiu Y; Chen Y; Jiang Z; Shen L; Shan H; Dai X; Li Q; Liu Y; Ren W; Ren J
Hum Vaccin Immunother; 2015; 11(10):2389-94. PubMed ID: 26158622
[TBL] [Abstract][Full Text] [Related]
19. Accelerated hepatitis B vaccination schedule among drug users: a randomized controlled trial.
Hwang LY; Grimes CZ; Tran TQ; Clark A; Xia R; Lai D; Troisi C; Williams M
J Infect Dis; 2010 Nov; 202(10):1500-9. PubMed ID: 20936979
[TBL] [Abstract][Full Text] [Related]
20. The response of hepatitis B vaccination on seronegative adults with different vaccination schedules.
Yao J; Li J; Chen Y; Shan H; Dai XW; Yang LN; Jiang ZG; Ren JJ; Xu KJ; Ruan B; Yang SG; Wang B; Xie TS; Li Q
Hum Vaccin Immunother; 2015; 11(5):1102-7. PubMed ID: 25621975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
